BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the ...
We are writing to set the record straight in response to the Vivo group’s recent press releases, lawsuits and other actions against SINOVAC and the Board, particularly those related to the Board’s ...
Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting Corrects the Record Following Latest ...
BEIJING - Chinese vaccine maker Sinovac Biotech Ltd. (NASDAQ:SVA) has received a second notification from Nasdaq regarding listing non-compliance, the company announced in a press release on Sunday.
Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results